US (re)insurance stocks follow Europe in Covid-19 vaccine surge

US (re)insurance stocks surged higher at the open, adding to a global market rally fuelled by news from drugmaker Pfizer and BioNTech on a breakthrough in the race to find a vaccine for Covid-19.

 

Want to read this article?

 

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Spencer Halladey

Commercial director

+44 (0) 77 4160 9085

spencer.halladey@thomsonreuters.com

    Andy Stone

    Sales manager

    +44 (0) 77 4160 9204

    andy.stone@thomsonreuters.com

      COVID-19
      Share price